Vendan Medicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-12-2024
- Paid Up Capital ₹ 0.20 M
as on 30-12-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.89 M
as on 30-12-2024
- Revenue 15.06%
(FY 2021)
- Profit 28.24%
(FY 2021)
- Ebitda 1.00%
(FY 2021)
- Net Worth 16.12%
(FY 2021)
- Total Assets 15.92%
(FY 2021)
About Vendan Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹9.89 M.
Vijayalakshmi Dhamodharan, Govindarajulu Rajaraman, and Tamilvendan Rajaraman serve as directors at the Company.
- CIN/LLPIN
U52300TN2012PTC084818
- Company No.
084818
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Thanjavur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vendan Medicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tamilvendan Rajaraman  | Managing Director | 07-Mar-2012 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijayalakshmi Dhamodharan | Director | 07-Mar-2012 | Current |
| Govindarajulu Rajaraman | Director | 07-Mar-2012 | Current |
Financial Performance of Vendan Medicals.
Vendan Medicals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 15.06% increase. The company also saw a substantial improvement in profitability, with a 28.24% increase in profit. The company's net worth Soared by an impressive increase of 16.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vendan Medicals?
In 2021, Vendan Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Parivendan Solutions Private LimitedActive 1 year 4 monthsVijayalakshmi Dhamodharan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 06 May 2022 | ₹1.00 M | Open |
City Union Bank Limited Creation Date: 10 Jan 2022 | ₹0.50 M | Open |
City Union Bank Limited Creation Date: 02 Aug 2021 | ₹1.39 M | Open |
How Many Employees Work at Vendan Medicals?
Unlock and access historical data on people associated with Vendan Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vendan Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vendan Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
